Theravance News

Macroaxis does not monitor all media channels or aggregates social signals for Theravance. But even though we do not provide professional-grade financial sentiment analysis on Theravance Inc, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Theravance. Also please take a look at World Market Map.
  
2 days ago at www.whatsonthorold.com         
As Buckeye Partners LP Stock Price Declined, Cohen Capital Management Has Raised Position by 548800 ...
news
Thorold NewsBuckeye Partners L.p. - BPL - Stock Price Today - Zacks Zacks Get full coverage
  
  
few days ago at stocknewstimes.com         
Theravance Biopharma Inc Expected to Announce Quarterly Sales of 3.71 Million
news
StockNewsTimesAs Theravance Biopharma Share Value Rose, Baupost Group Has Increased by 1.20 Million Its Holding ... Wolcott DailyEPS for Theravance Biopharma, Inc. Expected At -1.15 8 Analysts Covering Waste Management, Inc. NormanObserver.com Get full coverage
  
  
few days ago at ledgergazette.com         
LSV Asset Management Purchases New Holdings in Innoviva Inc
news
The Ledger Gazette0.52 EPS Expected for Innoviva Inc This Quarter StockNewsTimes Get full coverage
  
  
six days ago at bzweekly.com         
Why Cf Woodford Equity Income Fund Reported Theravance Biopharma, Inc Position
news
BZ WeeklyEPS for Theravance Biopharma, Inc. Expected At -1.15 ReuropeTheravance Biopharma, Inc. Analysts See -1.15 EPS KL Daily Get full coverage
  
  
over a week ago at markets.businessinsider.com         
Sarissa Capital Reconstitutes Innoviva Board Of Directors
businessinsider News
This outcome is the result of a proxy contest Sarissa Capital waged in connection with Innoviva 2017 annual stockholder meeting and Sarissa Capital necessary subsequent litigation against Innoviva. In December 2017, Sarissa Capital prevailed in its ...
  
  
over a week ago at stocknewsgazette.com         
Comparing Valuation And Performance Innoviva, Inc. , Remark Holdings ...
news
The shares of Innoviva, Inc. have increased by more than 8.74 percent this year alone. The shares recently went up by 11.81 percent or 1.63 and now trades at 15.43. Innoviva, Inc. recently sold by insider Aguiar Michael W - Post Analyst Innoviva Lifted to Hold at Zacks Investment Research - Dispatch Tribunal
  
  
over a week ago at www.concordregister.com         
Innoviva, Inc. Stock Sees Movement of 7.23 percent on the Week
news
Innoviva, Inc. closed at 15.43 after seeing 2749212 shares trade hands during the most recent session. Innoviva Inc Receives 12.50 Consensus Target Price from Analysts - registrarjournal.com Dimensional Fund Advisors LP Increases Stake in Innoviva Inc - TrueBlueTribune
  
  
over a week ago at stocknewstimes.com         
Immune Pharmaceuticals vs. Theravance Biopharma Critical Review
news
StockNewsTimes Get full coverage
  
  
over a week ago at flbcnews.com         
Current Broker Rating in Focus on Shares of Theravance Biopharma, Inc.
news
FLBC News Get full coverage
  
  
over a week ago at www.chron.com         
Innoviva beats Street 4Q forecasts
news
BRISBANE, Calif. Innoviva Inc. on Thursday reported fourth-quarter earnings of 58.4 million. The Brisbane, California-based company said it had profit of 45 cents per share.
  
  
over a week ago at expertgazette.com         
Analysts Reveals Updates on Innoviva Inc
news
Innoviva Inc shares traded 0.36 percent up during most recent session to reach at the closing price of 13.99. The stock exchanged hands 1.71 Million shares versus average trading capacity of 827.28 Million shares, yielding a market cap of 1.56 ... 0.45 EPS Expected for Innoviva, Inc. - BZ Weekly Zacks Investment Research Downgrades Innoviva to Sell - StockNewsTimes
  
  
over two weeks ago at finnewsweek.com         
What Story Are The Numbers Telling For Innoviva, Inc. Shares
news
The Price to Book ratio for Innoviva, Inc. NasdaqGSINVA is -6.971364. The Price to book ratio is the current share price of a company divided by the book value per share.
  
  
over two weeks ago at ledgergazette.com         
Innoviva Scheduled to Post Quarterly Earnings on Wednesday
news
Innoviva is set to issue its quarterly earnings data after the market closes on Wednesday, February 7th. Analysts expect the company to announce earnings of 0.38 per share for the quarter. Innoviva, Inc. Investor Update and Valuation Review - DARC News Innoviva Stock Rating Lowered by Zacks Investment Research - Week Herald
  
  
over two weeks ago at ledgergazette.com         
Head-To-Head Contrast Tetraphase Pharmaceuticals vs. Innoviva NASDAQ ...
news
Innoviva logo Innoviva, Inc., formerly Theravance, Inc., is engaged in the development, commercialization and financial management of bio-pharmaceuticals.
  
  
over two weeks ago at www.truebluetribune.com         
Innoviva Inc Shares Bought by Dimensional Fund Advisors LP
news
Dimensional Fund Advisors LP grew its stake in Innoviva Inc by 22.4 percent in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. Innoviva Downgraded by Zacks Investment Research to Sell - The Lincolnian Online
  

Latest Stories

Recently Published Macroaxis Headlines
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Theravance Inc to your portfolio

Pair Trading

Theravance Pair Trading Analysis
Correlation analysis and pair trading evaluation for Theravance and Vedanta Limited. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  
Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker